Syngene International Ltd
22 February 2025 13:48|BSE : 539268|NSE : SYNGENE|ISIN : INE398R01022
22 February 2025 13:48|BSE : 539268
NSE : SYNGENE|ISIN : INE398R01022
Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. The Company is a public limited company incorporated
Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. The Company is a public limited company incorporated
FAQs
How to buy Syngene International Ltd shares?
What is the current Market Cap of Syngene International Ltd?
What is the current PE and PB ratio of Syngene International Ltd?
Open Free Demat Account
Kickstart your investment journey